Expression and roles of CDK4 and p21 in lung tissues of premature rats with hyperoxia-induced lung disease

Chinese Journal of Contemporary Pediatrics

Volumn 9, Issue 6, 2007, Pages 595-600

  Gao, Ying ^a   Xue, Xin Dong ^a   Li, Jin Yang ^a   Wang, Ni ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Cell proliferation; Chronic lung disease; Hyperoxia; Lung cell; Premature rats

Indexed keywords

CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CHRONIC LUNG DISEASE; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HYPEROXIA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LUNG ALVEOLUS CELL; LUNG PARENCHYMA; NONHUMAN; PREMATURITY; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; TISSUE CULTURE;

ANIMALS; ANIMALS, NEWBORN; BRONCHOPULMONARY DYSPLASIA; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FEMALE; HUMANS; HYPEROXIA; INFANT, NEWBORN; LUNG; MALE; PROLIFERATING CELL NUCLEAR ANTIGEN; PULMONARY FIBROSIS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 38049055698     PISSN: 10088830     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Cederqvist K, Sorsa T, Tervahartiala T, Maisi P, Reunanen K, Lassus P, et al. Matrix metalloproteiinases-2, -8, and-9 and TIMP-2 in tracheal aspirates from preterm infants with respiratory distress [J]. Pediatrics, 2001, 108(3):686-692.
2. O'Reilly MA, Stavensky RJ, Watkins RH, Reed CK, de Mesy Jensen KL, Finkelstein JN, et al. The cyclin-dependent kinase inhibitor p21 protects the lung from oxidatine stress [J]. Am J Respir Cell Mol Biol, 2001, 24(6):703-710.
3. Radomski A, Sawicki G, Olson DM, Radomski MW. The role of nitric oxide and metalloproteinases in the pathogenesis of hyperoxia-induced lung injury in newborn rats[J]. Br J Pharmacol, 1998, 125(7):1455-1465.
4. 1 causes airway fibrosis and increased collagen I and III mRNA in mice [J]. Thorax, 2003, 58(9):772-777.
5. Chinese source.
6. Tashcroft T, Simpson JM, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale [J]. J Clin Pathol, 1988, 41(2):467-470.
7. Jobe AH, Banealari E. Bronchopulmonary dysplasia [J]. Am J Respir Crit Care Med, 2001, 163(7):1723-1729.
8. American Cademy of Pediatrics, Committee on Fetus and Newborn. Postnatal coticosteroids to treat or prevent chronic lung disease in preterm infants [J]. Pediatrics, 2002, 109(2):330-338.
9. Chinese source.
10. Hall PA, Levison DA, Woods AL, Yucc, Kellock DB, Watkins JA, et al. Proliferating cell nuclear antigen immulocalization in paraffin in section: an index of cell proliferation with evidence deregulated expression in some neoplasms[J]. J Pathol, 1990, 162 (4):285-293.
11. Staversky RJ, Watkins RH, Wright TW, Hemady E, LoMonaco MB, D'Angio CT, et al. Normal remodeling of the oxygen-injured lung requires the cyclin- dependent kinase inhibitor p21 (Cip1/WAF1/Sdi1) [J]. Am J Pathol, 2002, 161(3):1383-1393.
12. Rancourt RC, Keng PC, Helt CE, O'Reilly MA. The role of p21 (Cip1/WAF1) in growth of epithelial cells exposed to hyperoxia [J]. Am J Physiol, 2001, 280(4):L617-L626.
13. Maniscalco WM, Watkins RH, O'Reilly MA, Shea CP. Increased epithelial cell proliferation in very premature baboons with chronic lung disease [J]. Am J Physiol Lung Cell Mol Physiol, 2002, 283(5):L991-L1001.
14. Wahl SM, McCartney-Francis N, Mengenhagen SE. Inflammatory and immunomodulatory roles of TGF-beta [J]. Immunol Today, 1989, 10(8): 258-261.
15. Chinese source.
16. O'Reilly MA, Vitiello PF, Gchen SC, Staversky RJ. p21 (Cip1/WAF1/Sdi1) does not affect expression of base excision DNA repair enzymes during chronic oxidative stress [J]. Antioxid Redox Signal, 2005, 7(5-6):719-725.
17. 1/S progression during hyperoxia[J]. Am J Physiol, 2004, 286(3):L506-513.
18. 1 - phase progression in transformed mouse fibroblasts [J]. Cancer, 2004, 108(2):200-206.
19. Des KC, Ravi D. Altered expression of cyclins and cdks in premature infant baboon model of bronchopulmonary dysplasia[J]. Antioxid Redox Signal, 2004, 6(1):117-127.
20. O'Reilly MA, Watkins RH, Staversky RJ, Maniscalco WM. Induced p21 Cip1 in premature baboons with CLD: implications for alveolar hypoplasia[J]. Am J Physiol, 2003, 285(4):L964-971.
21. Inoshima, Kuwano K, Hamada N, Yoshimi M, Maeyama T, Hagimoto N, et al. Induction of CDK inhibitor p21 gene as a new therapeutic strategy against pulmonary fibrosis [J]. Am J Physiol, 2004, 286(2):L727-733.
22. Zhou Z, Song R, Fattman CL, Greenhill S, Albers, Oury TD. Carbon monoxide suppresses bleomycin-induced lung fibrosis[J]. Am J Pathol, 2005, 166(1):27-37.
23. Blundell R, Kaminski N, Harrison D. Increase in p21 expression independent of the p53 pathway in bleomycin-induced lung fibrosis [J]. Exp Mol Pathol, 2004, 77(3):231-237.